Floatz logo

Vidutolimod

Lymph Node Cancer

Diwakar Davarnucleic_acidPhase 2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Lymph Node Cancer cohort.

Asset / SponsorPhaseRating
Nivolumab
Diwakar Davar
Phase 2B

Same molecule, other indications

Vidutolimod is also rated in:

melanomaDormant
CCC
Indicative ·
52 / 100
View asset →
metastatic melanomaDormant
CCC
Indicative ·
49 / 100
View asset →
non-small cell lung carcinomaDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →